Skip to content

Drug interactions

Mirdametinib + Probenecid

Severity: Moderate

Mirdametinib and Probenecid: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Probenecid inhibits UGT enzymes and may increase mirdametinib exposure. No clinical studies have evaluated this, so the magnitude is unknown. Higher exposure could worsen MEK inhibitor toxicities such as rash or cardiomyopathy.

What this interaction means in plain words

Mirdametinib and Probenecid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mirdametinib belongs to Oncology; Probenecid belongs to Genitourinary.

Evidence level: Low

Why it happens

Probenecid inhibits UGT-mediated glucuronidation of mirdametinib.

What to do

Monitor for mirdametinib adverse effects such as rash and decline in cardiac function. Consider an alternative to probenecid if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mirdametinib and Probenecid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mirdametinib with Probenecid?

MediHelp rates the interaction as moderate. Mirdametinib and Probenecid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Probenecid inhibits UGT enzymes and may increase mirdametinib exposure. No clinical studies have evaluated this, so the magnitude is unknown. Higher exposure could worsen MEK inhibitor toxicities such as rash or cardiomyopathy.

How serious is the interaction between Mirdametinib and Probenecid?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for mirdametinib adverse effects such as rash and decline in cardiac function. Consider an alternative to probenecid if toxicity develops.

What other medicines interact with Mirdametinib?

MediHelp also lists interactions of Mirdametinib with, for example, Diclofenac, Rifampicin. The full list is on the Mirdametinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in